21 CFR 522.1289

§ 522.1289 Lufenuron.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.1289, § 522.1289 Lufenuron, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87476
Permanent ID: ys:prov:87476@1
SHA-256: 2e52e46f151cfc5154f80c4a6b20526325d7277aa7f4807fdd496a2a2be13056

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of suspension contains 100 milligrams (mg) of lufenuron. (b) Sponsor. See No. 058198 in § 510.600(c) of this chapter. (c) Conditions of use in cats—(1) Amount. 10 mg per kilogram (4.5 mg per pound) of body weight every 6 months, by subcutaneous injection. (2) Indications for use. For control of flea populations in cats 6 weeks of age and older. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.